Re:23andMe has signed a $300M deal with GlaxoSmithKline
by ehsankia on Saturday January 05, 2019 @05:46PM
(#18834792)
The compensation is subsidized genetic testing. Without these deals, I'm sure the service would cost a lot more. I agree that being opt-in is important here, at the very least because people who signed on early did not agree to this. In the long term, if they changed it, I'm sure it'd require a new terms, and that older users would be grandfathered into the opt-out.
[ Parent
| on HN ]
There are no comments on this comment yet.